Adaptimmune Therapeutics (ADAP) Stock Chart & Stock Price History $0.60 +0.00 (+0.82%) (As of 12/20/2024 05:51 PM ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Adaptimmune Therapeutics Stock Price Performance 5 Day Performance+2.28%1 Month Performance-4.45%3 Month Performance-39.27%6 Month Performance-32.03%Year-To-Date Performance-23.72%1 Year Performance+27.97% Receive ADAP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Adaptimmune Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now ADAP Stock Chart for Saturday, December, 21, 2024 ADAP Chart by TradingView Adaptimmune Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/20/2024$0.60$0.60+0.82%$0.61$0.593.10 million shs$154.78 million12/19/2024$0.61$0.60-0.99%$0.62$0.582.38 million shs$153.53 million12/18/2024$0.60$0.61+1.10%$0.63$0.593.27 million shs$155.07 million12/17/2024$0.59$0.60+1.35%$0.61$0.572.62 million shs$153.38 million12/16/2024$0.58$0.59+1.95%$0.60$0.572.61 million shs$151.33 million12/13/2024$0.63$0.58-8.14%$0.62$0.553.03 million shs$148.44 million Get the Latest News and Ratings for ADAP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Adaptimmune Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/12/2024$0.64$0.63-0.55%$0.65$0.612.05 million shs$161.59 million12/11/2024$0.62$0.64+1.94%$0.65$0.611.27 million shs$162.48 million12/10/2024$0.63$0.62-0.51%$0.65$0.615.35 million shs$159.39 million12/09/2024$0.66$0.63-4.86%$0.67$0.612.04 million shs$160.21 million12/06/2024$0.67$0.66-2.39%$0.68$0.641.55 million shs$168.40 million12/05/2024$0.70$0.67-3.69%$0.74$0.652.00 million shs$172.51 million12/04/2024$0.70$0.70+0.23%$0.70$0.662.56 million shs$179.12 million12/03/2024$0.72$0.70-3.43%$0.73$0.68669,612 shs$178.71 million12/02/2024$0.72$0.72+0.35%$0.74$0.703.15 million shs$185.05 million11/29/2024$0.73$0.72-0.59%$0.74$0.72220,906 shs$184.41 million11/28/2024$0.73$0.73$0.73$0.683.32 million shs$185.51 million11/27/2024$0.68$0.73+6.62%$0.73$0.683.31 million shs$185.51 million11/26/2024$0.70$0.68-2.45%$0.71$0.68383,202 shs$174.00 million11/25/2024$0.66$0.70+5.37%$0.71$0.661.43 million shs$178.37 million11/22/2024$0.63$0.66+4.50%$0.66$0.601.34 million shs$169.29 million11/21/2024$0.66$0.63-4.75%$0.68$0.63751,190 shs$162.00 million11/20/2024$0.67$0.66-1.50%$0.71$0.644.16 million shs$170.08 million Related Companies ORIC Stock Price Chart TERN Stock Price Chart TRML Stock Price Chart PHAT Stock Price Chart PROK Stock Price Chart ATXS Stock Price Chart DNA Stock Price Chart ANNX Stock Price Chart HUMA Stock Price Chart PRTC Stock Price Chart Receive ADAP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Adaptimmune Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ADAP) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adaptimmune Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Adaptimmune Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
